Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Limited extent and consequences of pancreatic SARS-CoV-2 infection
Verena van der Heide, Sonia Jangra, Phillip Cohen, et al.
Cell Reports (2022) Vol. 38, Iss. 11, pp. 110508-110508
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Risks and burdens of incident diabetes in long COVID: a cohort study
Yan Xie, Ziyad Al‐Aly
The Lancet Diabetes & Endocrinology (2022) Vol. 10, Iss. 5, pp. 311-321
Open Access | Times Cited: 456
Two Years into the COVID-19 Pandemic: Lessons Learned
Severino Jefferson Ribeiro da Silva, Jéssica Catarine Frutuoso do Nascimento, Renata Pessôa Germano Mendes, et al.
ACS Infectious Diseases (2022) Vol. 8, Iss. 9, pp. 1758-1814
Open Access | Times Cited: 103
Incidence of new-onset in-hospital and persistent diabetes in COVID-19 patients: comparison with influenza
Justin Y. Lu, Jack Wilson, Wei Hou, et al.
EBioMedicine (2023) Vol. 90, pp. 104487-104487
Open Access | Times Cited: 44
Risk of incident diabetes post-COVID-19: A systematic review and meta-analysis
Mainak Banerjee, Rimesh Pal, Sulagna Dutta
Primary care diabetes (2022) Vol. 16, Iss. 4, pp. 591-593
Open Access | Times Cited: 54
SARS-CoV-2 and type 1 diabetes in children in Finland: an observational study
Mikael Knip, Anna Parviainen, Maaret Turtinen, et al.
The Lancet Diabetes & Endocrinology (2023) Vol. 11, Iss. 4, pp. 251-260
Open Access | Times Cited: 30
New-Onset Diabetes After COVID-19
Sun H. Kim, Ipsa Arora, Daniel S. Hsia, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 108, Iss. 11, pp. e1164-e1174
Closed Access | Times Cited: 25
Patients with prediabetes are at greater risk of developing diabetes 5 months postacute SARS-CoV-2 infection: a retrospective cohort study
A Xu, Stephen Wang, Timothy Q. Duong
BMJ Open Diabetes Research & Care (2023) Vol. 11, Iss. 3, pp. e003257-e003257
Open Access | Times Cited: 23
Infection with SARS-CoV-2 can cause pancreatic impairment
Wei Deng, Linlin Bao, Zhiqi Song, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 9
Generation of functional thymic organoids from human pluripotent stem cells
Stephan A. Ramos, Lucas H. Armitage, J. Jason Morton, et al.
Stem Cell Reports (2023) Vol. 18, Iss. 4, pp. 829-840
Open Access | Times Cited: 18
Is COVID-19 to Blame? Trends of Incidence and Sex Ratio in Youth-Onset Type 2 Diabetes in Germany
Christian Denzer, Joachim Rosenbauer, Daniela Klose, et al.
Diabetes Care (2023) Vol. 46, Iss. 7, pp. 1379-1387
Open Access | Times Cited: 15
The countdown to type 1 diabetes: when, how and why does the clock start?
Anette‐Gabriele Ziegler
Diabetologia (2023) Vol. 66, Iss. 7, pp. 1169-1178
Open Access | Times Cited: 15
Diabetes Mellitus, Energy Metabolism, and COVID-19
Caterina Conte, Elisa Cipponeri, Michael Roden
Endocrine Reviews (2023) Vol. 45, Iss. 2, pp. 281-308
Open Access | Times Cited: 15
The relationship between SARS-CoV-2 infection and type 1 diabetes mellitus
Cyril Debuysschere, Magloire Pandoua Nekoua, Enagnon Kazali Alidjinou, et al.
Nature Reviews Endocrinology (2024) Vol. 20, Iss. 10, pp. 588-599
Closed Access | Times Cited: 5
Risk assessment of hypertensive and metabolic disorders in pregnant women with COVID-19
И. В. Жуковец, I. A. Andrievskaya, N. A. Кrivoshchekova, et al.
Сибирский научный медицинский журнал (2025) Vol. 44, Iss. 6, pp. 203-209
Open Access
Host factor PLAC8 is required for pancreas infection by SARS-CoV-2
Lesly Ibargüen-González, Sandra Heller, Darío López-García, et al.
Communications Medicine (2025) Vol. 5, Iss. 1
Open Access
SARS‐CoV‐2 cellular tropism and direct multiorgan failure in COVID‐19 patients: Bioinformatic predictions, experimental observations, and open questions
Anna A. Valyaeva, Anastasia A. Zharikova, Eugene V. Sheval
Cell Biology International (2022) Vol. 47, Iss. 2, pp. 308-326
Open Access | Times Cited: 22
The COVID-19 Pandemic Affects Seasonality, With Increasing Cases of New-Onset Type 1 Diabetes in Children, From the Worldwide SWEET Registry
Felix Reschke, Stefanie Lanzinger, Vivien Herczeg, et al.
Diabetes Care (2022) Vol. 45, Iss. 11, pp. 2594-2601
Open Access | Times Cited: 19
Increased Severity of Presentation Signs in Children with Newly Diagnosed Type 1 Diabetes during the COVID-19 Pandemic: A Tertiary Center Experience
Elif İzci Güllü, Leyla Akın, Mehmet Enes Gökler, et al.
Annals of Nutrition and Metabolism (2024) Vol. 80, Iss. 3, pp. 161-170
Closed Access | Times Cited: 3
Rising diabetes diagnosis in long COVID
K.M. Venkat Narayan, Lisa R. Staimez
The Lancet Diabetes & Endocrinology (2022) Vol. 10, Iss. 5, pp. 298-299
Open Access | Times Cited: 14
Respiratory infections and type 1 diabetes: Potential roles in pathogenesis
Roy Wu, Mohsin Mumtaz, Anna J. Maxwell, et al.
Reviews in Medical Virology (2023) Vol. 33, Iss. 2
Open Access | Times Cited: 8
Examining the associations between COVID-19 infection and pediatric type 1 diabetes
Bruno Bombaci, Stefano Passanisi, Lacrima Sorrenti, et al.
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 5, pp. 489-497
Closed Access | Times Cited: 8
New‐onset type 1 diabetes and severe acute respiratory syndrome coronavirus 2 infection
Roy Anindya, Guy A. Rutter, Gargi Meur
Immunology and Cell Biology (2022) Vol. 101, Iss. 3, pp. 191-203
Open Access | Times Cited: 11
COVID-19 and diabetes — where are we now?
Rüdiger Groß, Alexander Kleger
Nature Metabolism (2022) Vol. 4, Iss. 12, pp. 1611-1613
Open Access | Times Cited: 10
Increase in newly diagnosed type 1 diabetes and serological evidence of recent SARS-CoV-2 infection: Is there a connection?
Marco Denina, Michela Trada, Davide Tinti, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 9
Susceptibilidade das células beta-pancreáticas ao SARS-CoV-2: uma revisão integrativa
Anna Cláudia Nunes, Anna Lucinda Truyts Lima Vaz Guimarães, Ciro Ferrari de Souza, et al.
Brazilian Medical Students (2024) Vol. 8, Iss. 12
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top